Iñaki Gutiérrez-Ibarluzea, N. Bolaños, Jan Geissler, Giovanni Gorgoni, Tara Lumley, Joseph Mikhael, Tamara Milagre, H. Poppel, L.E.K Consultant, Consulting
{"title":"Beyond Overall Survival: The Value of Oncology- Relevant Endpoints in HTA Body / Payer Decision-Making","authors":"Iñaki Gutiérrez-Ibarluzea, N. Bolaños, Jan Geissler, Giovanni Gorgoni, Tara Lumley, Joseph Mikhael, Tamara Milagre, H. Poppel, L.E.K Consultant, Consulting","doi":"10.29011/2574-710x.10181","DOIUrl":null,"url":null,"abstract":"Introduction : HTA bodies/payers have focused on overall survival (OS) to evaluate oncology medicine’s efficacy during decision-making. While OS remains important, reliance on it poses three challenges: potential delayed patient access to medicines due","PeriodicalId":73876,"journal":{"name":"Journal of oncology research and therapy","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of oncology research and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-710x.10181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction : HTA bodies/payers have focused on overall survival (OS) to evaluate oncology medicine’s efficacy during decision-making. While OS remains important, reliance on it poses three challenges: potential delayed patient access to medicines due
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
